Effect of Cranberry Capsules on Urinary Infection Rates in Spinal Cord Injured Patients During Post Acute Rehabilitation
Not Applicable
Terminated
- Conditions
- Spinal Cord InjuryUrinary Tract InfectionRehabilitation
- Interventions
- Dietary Supplement: Cranberry capsules
- Registration Number
- NCT01079169
- Lead Sponsor
- Uppsala University
- Brief Summary
The purpose of this study is to establish whether cranberry capsules reduce rates of urinary tract infections during initial rehabilitation immediately after spinal cord injury.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
- Previously essentially healthy
- Newly acquired spinal cord injury, T12 level or higher
- Receiving in-patient care on the rehabilitation ward.
- Expected admission duration >= 4 weeks
- 16 years old or older
Exclusion Criteria
- Current or previous disorder that increases the risk of urinary tract infection including diabetes, urological disorder, previous operation on urinary tracts or kidneys, immune dysfunction
- Severe head injury with impairment of cognitive function
- Allergy to cranberry
- Renal failure
- Warfarin (Coumarin) treatment with unstable INR
- Current symptomatic urinary tract infection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cranberry capsule Cranberry capsules - Placebo capsule Cranberry capsules -
- Primary Outcome Measures
Name Time Method Number of symptomatic urinary tract infections per patient per month during in-patient post acute rehabilitation At end of study
- Secondary Outcome Measures
Name Time Method Percentage of in-patient rehabilitation days on which patients were unable to participate in active rehabilitation due to urinary tract infection. At end of Study Patient's experience of urinary symptoms in the absence of symptomatic urinary tract infection. At end of study
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of cranberry capsules inhibit uropathogenic E. coli adhesion in spinal cord injured patients?
How does cranberry capsule efficacy compare to prophylactic antibiotics for UTI prevention in post-acute spinal cord injury rehabilitation?
Which urinary biomarkers correlate with cranberry capsule effectiveness in preventing UTIs in neurogenic bladder patients?
What are the safety profiles and potential nephrotoxicity risks of cranberry supplementation in spinal cord injury populations?
Are there synergistic effects when combining cranberry capsules with probiotics like Lactobacillus for UTI prevention in neurogenic bladder management?
Trial Locations
- Locations (1)
Dept of Rehabilitation Medicine, University Hospital
🇸🇪Uppsala, Sweden
Dept of Rehabilitation Medicine, University Hospital🇸🇪Uppsala, Sweden